MRD / Regn No. : SG002407 Date : 07/07/2026
Patient Name : Subrata SenGupta Age & Gender : 71 Yrs. / Male
Contact No. : 9436460224 UHID :
Ht / Wt / BMI : 170 / 65 / 22.49 BP S / BP D : 164 / 69
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (17/Apr/2000) |
Salient Investigations : CREATININE: 1.3 | EGFR EGLOMERULAR FILTRATION RATE: 57.96 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 225 mg/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 14.1 % | MICROALBUMIN CREATININE RATIO: 181.2 mcg/mg | POST PRANDIAL GLUCOSE (2HPP): 281 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 ATORVASTATIN 20
ATOCOR 		PO 0-0-1 BEFORE DINNER
 TILL NEXT VISIT
2 TELMISARTAN 20
TELDAY 20 		PO 1-0-0 BEFORE DINNER
 TILL NEXT VISIT
3 TABLET FINERENONE 20 MG
LYVELSA 20 MG 		PO 1-0-0 BEFORE BREAKFAST
4 TABLET ACARBOSE 50 MG
GLUCOBAY 50 MG
Medicine For DIABETES 		PO 0-1-0 BEFORE LUNCH
 TILL NEXT VISIT
5 ANTIHYPERGLYCEMIC GLIMIPERIDE 2 MG + METFORMIN 500 MG
GEMER 2 MG 		PO 1-0-1 BEFORE BREAKFAST AND DINNER
 TILL NEXT VISIT
6 INJECTION GLARGINE (INJ U100)
LANTUS
Medicine For GLUCOSE CONTROL 		SQ 0-0-50 AT BEDTIME
 TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
7 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG + LINAGLIPTIN 5 MG
OXRA L 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 07/Jan/2027
Tests Suggested For Next Visit : SMBG,CHECK CREATININE,UACR:SPOT SAMPLE,AND SERUM POTASSIUM AFTER 4 WEEKS AND INFORM,HBA1C-HPLC METHOD,CREATININE,RETINA CHECK UP
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: